ASCO 2020
News/ News/ News/ Oncology/ R&D
AZ nabs a positive study for Imfinzi plus tremelimumab in liver cancer
Phil Taylor
ASCO 2020, AstraZeneca, Imfinzi, immuno-oncology, Liver cancer, Oncology, tremelimumab
0 Comment
Oncology/ Views & Analysis/ Views and analysis
ASCO 2020 virtual annual meeting – day 3
mike.hammerton@pharmaphorum.com
asco, ASCO 2020, cancer, Oncology
0 Comment
News/ News/ News/ Oncology/ R&D
ASCO data back AZ/Daiichi Sankyo’s Enhertu in new HER2 cancers
Phil Taylor
ASCO 2020, AstraZeneca, colorectal cancer, Daiichi Sankyo, her2, lung cancer, stomach cancer
0 Comment
News/ News/ News/ Oncology/ R&D
Competition heats up in BCMA CAR-T as J&J, BMS update myeloma trials
Phil Taylor
ASCO 2020, Bristol-Myers Squibb, CAR T, Johnson & Johnson, multiple myeloma
0 Comment
Oncology/ Views & Analysis/ Views and analysis
ASCO 2020 virtual annual meeting – day 2
mike.hammerton@pharmaphorum.com
asco, ASCO 2020, cancer, Oncology
0 Comment
Oncology/ Views & Analysis/ Views and analysis
ASCO 2020 virtual annual meeting – day 1
mike.hammerton@pharmaphorum.com
asco, ASCO 2020, cancer, Oncology
0 Comment